These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 11404731
1. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment. Van Woensel JB, Kimpen JL, Brand PL. Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731 [Abstract] [Full Text] [Related]
2. Therapy for respiratory tract infections caused by respiratory syncytial virus. van Woensel J, Kimpen J. Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842 [Abstract] [Full Text] [Related]
3. Respiratory syncytial virus disease: update on treatment and prevention. Krilov LR. Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875 [Abstract] [Full Text] [Related]
4. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile? Hashmi NA, Cosgrove JF, MacMahon P. Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917 [Abstract] [Full Text] [Related]
5. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Wendt CH, Hertz MI. Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850 [Abstract] [Full Text] [Related]
6. Respiratory syncytial virus infection in infants and young children. Levy BT, Graber MA. J Fam Pract; 1997 Dec; 45(6):473-81. PubMed ID: 9420581 [Abstract] [Full Text] [Related]
10. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Liu V, Dhillon GS, Weill D. Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558 [Abstract] [Full Text] [Related]
11. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443 [Abstract] [Full Text] [Related]
12. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Cooper AC, Banasiak NC, Allen PJ. Pediatr Nurs; 2003 Dec; 29(6):452-6. PubMed ID: 14743842 [Abstract] [Full Text] [Related]
13. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Transplantation; 2009 Nov 27; 88(10):1222-6. PubMed ID: 19935377 [Abstract] [Full Text] [Related]
17. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season. Singleton RJ, Bruden D, Bulkow LR, Varney G, Butler JC. Pediatr Infect Dis J; 2006 Dec 27; 25(12):1116-22. PubMed ID: 17133156 [Abstract] [Full Text] [Related]
18. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy. Medici MC, Arcangeletti MC, Merolla R, Chezzi C, Osservatorio VRS Study Group. Acta Biomed; 2004 Apr 27; 75(1):26-33. PubMed ID: 15315084 [Abstract] [Full Text] [Related]
19. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. McColl MD, Corser RB, Bremner J, Chopra R. Bone Marrow Transplant; 1998 Feb 27; 21(4):423-5. PubMed ID: 9509980 [Abstract] [Full Text] [Related]